Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View Item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.

Thumbnail
View/Open
Supporting information (63.31Kb)
Publication Date
2017-06
ICR Author
Marsden,
Author
Ferrari, A
Trama, A
De Paoli, A
Bergeron, C
Merks, JHM
Jenney, M
Orbach, D
Chisholm, JC
Gallego, S
Glosli, H
De Salvo, GL
Botta, L
Gatta, G
Bisogno, G
RARECAREnet Working Group
Type
Journal Article
Metadata
Show full item record
Abstract
<h4>Background</h4>Adolescents with cancer are enrolled in clinical trials at far lower rates than children. This report compares the number of adolescents (15-19-year-olds) and children (0-14-year-olds) enrolled in the protocols of the European pediatric Soft tissue sarcoma Study Group (EpSSG) with the number of cases expected to occur.<h4>Methods</h4>The observed-to-expected (O/E) ratio was detected in the EpSSG countries contributing most of the cases, that is, Italy, France, Spain, the Netherlands, United Kingdom, and Ireland. The observed cases included patients enrolled in any of the EpSSG protocols from October 2008 to October 2015, when all EpSSG protocols were open in these countries. The number of expected cases was calculated from the incidence rates estimated throughout the RARECAREnet database in the countries' population-based cancer registries.<h4>Results</h4>In the countries considered, 2,118 cases aged 0-19 years were enrolled in the EpSSG trials from 2008 to 2015: 82.8% were children and 17.2% were adolescents. The O/E ratio was 0.30 among patients 15-19 years old, as opposed to 0.64 for those 0-14 years old. The O/E ratio differed for the different subtypes: in adolescents, it was 0.64 and 0.18 for rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcomas (NRSTS), respectively; in children, it was 0.77 and 0.50, respectively. The O/E ratios differed across the countries considered.<h4>Conclusions</h4>Adolescents were less well represented than children on the EpSSG protocols, with better enrolment for RMS than for NRSTS for all age groups.
URL
https://repository.icr.ac.uk/handle/internal/1361
Collections
  • Other ICR Research
Version of record
10.1002/pbc.26348
Subject
RARECAREnet Working Group
Humans
Rhabdomyosarcoma
Retrospective Studies
Age Factors
Adolescent
Adult
Child
Child, Preschool
Infant
Infant, Newborn
Health Services Accessibility
Europe
Female
Male
Clinical Trials as Topic
Language
eng
Date accepted
2016-10-12
License start date
2017-06
Citation
Pediatric blood & cancer, 2017, 64 (6)

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.